• 제목/요약/키워드: p67

검색결과 5,698건 처리시간 0.034초

Clinicopathology Significance of p53 and p63 Expression in Indonesian Cervical Squamous Cell Carcinomas

  • Romus, Ilhami;Triningsih, F.X. Ediati;Mangunsudirdjo, Sagiri;Harijadi, Ahmad
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권12호
    • /
    • pp.7737-7741
    • /
    • 2013
  • Background: Human papilloma virus infection is associated with genesis and malignant potential of cervical cancer. E6 and E7 oncogens are known to bind to p53 and retinoblastoma gene products, abrogating their functions as tumor suppressors, leading to an abnormal cell cycle machinery. Roles of the p53 homolog p63 have also been postulated, E6 expression leading to TAp63b degradation allowing anchorage independent growth. Molecular studies correlated with clinicopathological factors are important to determine prognosis and treatment strategies, but results have been controversial and need to be clarified. Aim: To investigate expression of p53 and p63 in cervical squamous cell carcinomas in correlation with age, FIGO staging, morphology, and cancer cell proliferation. Materials and Methods: Expression of p53 and p63 immunohistochemical staining in a total of 56 paraffin-embedded tissues of cervical squamous cell carcinomas from Dr. Sardjito General Hospital Indonesia, was evaluated for correlation with clinicopathological parameters. The Mann-Whitney test was used to compare the percentage of p53 and p63 expression with patient age, FIGO staging and morphology and to compare mean p53 and p63 expression. The Spearman correlation test was applied to correlate p53 and p63 expression with that of Ki-67. A p-value of <0.05 was considered statistically significant. Results: There were significant associations between p53 expression with age (p=0.019) and FIGO staging (p=0.026), but not with with morphology or Ki-67 expression. There were no links between p63 expression and age, morphology, FIGO staging or Ki-67. Conclusions: This study indicated that p53 has a prognostic value in cervical squamous cell carcinomas given the relation with FIGO staging.

Prognostic Factors of Prostate Cancer in Tunisian Men: Immunohistochemical Study

  • Missaoui, Nabiha;Abdelkarim, Soumaya Ben;Mokni, Moncef;Hmissa, Sihem
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권5호
    • /
    • pp.2655-2660
    • /
    • 2016
  • Background: Prostate cancer is the second most common male cancer and remains a leading cause of cancer death worldwide. Heterogeneity regarding recurrence, tumor progression and therapeutic response reflects the inadequacy of traditional prognostic factors and underlies interest in new genetic and molecular markers. In this work, we studied the prognostic value of the expression of 9 proteins, Ki-67, p53, Bcl-2, PSA, HER2, E-cadherin, $p21^{WAF1/Cip1}$, $p27^{Kip1}$ and $p16^{ink4a}$ in prostate cancer. Materials and Methods: We conducted a retrospective study of 50 prostate cancers diagnosed in Pathology Department of Farhet Hached Hospital, Sousse, Tunisia, during a period of 12 months. Clinico-pathological data and survival were investigated. Protein expression was analyzed by immunohistochemistry on archived material. Results: Expression or over-expression of Ki-67, p53, Bcl-2, PSA, HER2, E-Cadherin, $p21^{WAF1/Cip1}$, $p27^{Kip1}$ and $p16^{ink4a}$ was observed in 68%, 24%, 32%, 78%, 12%, 90%, 20%, 44% and 56% of cases, respectively. Overall five-year survival was 68%. A statistically significant correlation was observed between death occurrence and advanced age (p=0.018), degree of tumor differentiation (p=0.0001), perineural invasion (p=0.016) and metastasis occurrence (p=0.05). Death occurrence was significantly correlated with the expression of p53 (p=0.007), Bcl-2 (p=0.02), Ki-67 (p=0.05) and $p27^{Kip1}$ (p=0.04). Conclusions: The p53, Bcl-2, Ki-67 and $p27^{Kip1}$ proteins may be useful additional prognostic markers for prostate cancer. The use of these proteins in clinical practice can improve prognosis prediction, disease screening and treatment response of prostatic cancer.

선박소음에 관한 연구 (THE STUDY ON THE NOISE IN THE VESSEL)

  • 박중희;김상한
    • 한국수산과학회지
    • /
    • 제8권4호
    • /
    • pp.202-207
    • /
    • 1975
  • 1975년 6월 7일에서 동년 8월 11일까지 풍양호(4,500H. P), 척양호(3,800H. P.), 동방호(3,000 H. P.), 오대산호(2,600 H. P.), 백경호(850 H. P.), 관악산호(1,000 H..P.) 계 6척의 기관실 소음을 주기관의 회전수에 따라 소음압이 변하는 것과 기관실 체격과 총 마력수에 따른 상관관계등을 조사한 결과를 요약하면 다음과 같다. 1. 각 선박의 총 마력수에 따라 기관실 체적이 비례로 커져가고 있으나 소음관계는 같은 종류의 기관(6기통)을 사용하고 있으므로 소음압이 낮아져 가는 경향을 보이는데 관악산초, 척양호, 동방호는 표준 곡선에 비해 소음압이 3dB정도 높은 경향을 보였고 백경호, 풍양호는 4dB 정도 낮은 경향을 보였다. 2. 각 주기관의 최대 회전수(r.p.m.)가 되기 전의 회전수에서 이미 최대의 소음압을 나타내고 있는데 그 회전수의 백분율은 선박에 따라 약간의 차이는 있으나 $67{\~}75{\%}$인 범위에서 최대소음이 되고 있다. 3. 각 기관실의 최대소음압은 $93.5{\~}105dB$의 범위 였고, stern trawl 선박구조를 가진 어획물 처리장은 81 dB 였는데 풍양호만은 72 dB로서 선원 상호간의 대화는 가능하였다. 4. 관악산호를 제외하고는 각 선박식당의 소음압은 $68{\~}75dB$, 싸롱은 $67{\~}72dB$ 선원실은$67{\~}75dB$ 학생실은$67{\~}72dB$였고 갑판의 소음압은 동방호를 제외하고는 $67{\~}72dB$의 범위였다.

  • PDF

토양병해 길항성 Pseudomonas maltophilia B-14의 길항유전자탐색 (Molecular Cloning of Antagonistic Genes in Pseudomonas maItophiliQ B-14)

  • 구본성;서영우;윤상홍;박경수;은무영;김용환;오상우;류진창;은무영
    • 한국미생물·생명공학회지
    • /
    • 제20권6호
    • /
    • pp.619-624
    • /
    • 1992
  • Tn5 lac 삽입으로 채소입고병원균에 길항력이 약화된 T-67 및 고추역병균과 참깨역병균에 길항력이 약화된 T-81의 Tn5 lac 유전자 일부와 오른쪽 말단에 있는 길항관련 유전자의 flanking sequence가 cloning된 pAG67 및 pAG81 clone을 선발하였고, pAG67 및 pAG81 clone된 길항관련 유전자의 flanking sequence를 야생 길항균 Pseudomonas maltophilia B-14의 DNA를 probe로 사용하여 Southern hybridization으로 확인하였으며, 제한효소 지도를 작성하여 8Kb 및 4Kb 크기의 flanking sequence가 cloning되었음을 확인하였다. pAG6 및 pAG81의 flanking sequence를 EcoRi-BglII와 EcoRI-MpaI으로 분리하여 유전자 은행으로부터 길항관련 유전자가 cloning된 cosmid clone 7개주를 선발하였다.

  • PDF

두경부 편평세포암에서 HMGI(Y), p53, Ki-67의 발현과 임상인자와의 상관 관계 (Correlation of Clinical Factors with HMGI(Y), p53 and Ki-67 Expression in Squamous Cell Carcinomas of the Head and Neck)

  • 노영수;박준영;박일석;임영창;문성호;김성동;황준식;김덕환
    • 대한두경부종양학회지
    • /
    • 제18권1호
    • /
    • pp.11-17
    • /
    • 2002
  • Objectives: Expression of HMGI(Y), a nucleoprotein that binds to A/T rich sequences in the minor groove of the DNA helix, is observed in neoplastically transformed cells but not in normal cells. We have analyzed HMGI(Y), p53 expression and Ki-67 labelling index in squamous cell carcinomas of the head and neck, and evaluated its clinicopathologic significance. Materials and Methods: 40 cases of squamous cell carcinoma of the head and neck were entered on the study of immunohistochemical stains for HMGI(Y), p53 and Ki-67. We analyzed the relationship between HMGI(Y), p53, Ki-67 expression and age, sex, primary tumor site, stage, survival rate, recurrence. Results: HMGI(Y) expression evidenced by immunohistochemical staining was observed in 35 of 40 (87.5%) squamous cell carcinoma of the head and neck. But no significant correlation was observed between HMGI(Y) expression and other clinical factors such as primary site, tumor stage, differenciation, cervical lymph node, metastasis, recurrence and immunohistochemical status of p53. The Ki-67 labelling index was significantly correlated with recurrence and HMGI(Y) expression (p<0.05). Conclusion: This results suggest the Ki-67 is a good prognostic factor and the HMGI(Y) expression plays some roles in carcinogenesis and cellular proliferation of squamous cell carcinoma of the head and neck. HMGI(Y) gene can be used as a cancer marker, the correlation between the gene expression and the prognosis of the cancer patient should be proved in the future studies.

Prognostic Significance of Expression of CD133 and Ki-67 in Gastric Cancer

  • Saricanbaz, Irem;Karahacioglu, Eray;Ekinci, Ozgur;Bora, Huseyin;Kilic, Diclehan;Akmansu, Muge
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권19호
    • /
    • pp.8215-8219
    • /
    • 2014
  • CD133 is one of the most important stem cell markers in solid cancers and Ki-67 is a marker that reflects cell proliferation. The relationships between the expression of CD133 and Ki-67 and prognosis in gastric carcinoma are unknown and need exploring. We examined 50 gastric cancer patients retrospectively in the Radiation Oncology Department of the Faculty of Medicine, Gazi University. CD133 and Ki-67 expression was examined using immunohistochemical staining. The survival rate in patients with CD133 positive expression was significantly worse than that in the patients with negative expression (p=0.04). Expression of CD133 had a positive correlation with that of Ki-67 (r=0.350; p=0.014). Multivariate analysis revealed that the expression of CD133 was an independent prognostic factor in gastric cancer (p=0.02). Conclusion, expression of CD133 may be a useful prognostic marker in gastric cancer.

육계의 조기제한사양이 보상성장과 사료효율 및 도체지방축적에 미치는 영향

  • 오용석;함영훈;이규호
    • 한국가금학회:학술대회논문집
    • /
    • 한국가금학회 2001년도 제18차 정기총회 및 학술발표 PROCEEDINGS
    • /
    • pp.99-101
    • /
    • 2001
  • Three experiments were conducted with broilers to study the effects of early feed restriction. In all studies, treatments were represented by three replicated floor pens, each containing 20 birds. In Experiment 1, broilers were fed at 0.75 kcal ME/g BW/sup0.67 for 3 d, 1.5kcal m/E BW/sup0.67 for 5 d or 2.25 kcal ME/g BW/sup0.67 for 7 d, all imposed beginning at 7 d of age. Birds were smaller following feed restriction(P<0.05), although growth compensation occurred, and at 49 d all restricted birds were same(P>0.05) to full-fed control buds in body weight. Growth compensation was associated with improved feed conversion(P<0.05), although carcass composition was unchanged. In a second study, all birds were fed at 0.75 kcal ME/g BW/sup0.67 for 3 or 5 d, starting at either 4, 7, or 10 d of age. When feed restriction was applied for shorter periods of time, growth compensation occurred(P>0.05). With more severe feed restriction, birds were smaller(P<0.05) at 49 d compared to control. Feed conversion was improved following prior feed restriction(P<0.05, 4 to 49). In a third trial, broilers were fed a starter diet diluted with 50% rice hulls. Birds failed to consume enough of this diluted feed, and so were initially smaller, However 49 d weight was not affected (P>0.05). When periods of 24 h feed withdrawal were imposed in conjunction with the diluted diets, birds were under weight at 49 d. It is concluded that physical feed restriction at 0.75 to 1.5 kcal ME/g BW$\^$0.67 imposed for 3 to 5 d in the early life currently presents the best option as a means of controlling broiler growth so as to improve feed efficiency.

  • PDF

p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence

  • Sawair, F;Hassona, Y;Irwin, C;Stephenson, M;Hamilton, P;Maxwell, P;Gordon, D;Leonard, A;Napier, S
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권3호
    • /
    • pp.1243-1249
    • /
    • 2016
  • Background: Expression of p53, cyclin D1, p21 (WAF1) and Ki-67 (MIB1) was evaluated in oral squamous cell carcinoma (OSCC) to test whether levels of these markers at invasive tumour fronts (ITFs) could predict the development of local recurrence. Materials and Methods: Archived paraffin-embedded specimens from 51 patients with T1/T2 tumours were stained immunohistochemically and analysed quantitatively. Local recurrence-free survival was tested with Kaplan-Meier survival plots (log-rank test) using median values to define low and high expression groups and with a Cox's proportional hazards model in which the expression scores were entered as continuous variables. Results: The assessment of expression of all markers was highly reliable, univariate analysis showing that patients with clear surgical margins, with low cyclin D1 and high p21 expression at the ITF had the best local recurrence-free survival. Multivariate analysis showed that these three parameters were independent prognostic factors but that neither p53 nor MIB1 expression were of prognostic value. Conclusions: Assessment of p53, cyclin D1, p21 (WAF1), and Ki-67 (MIB1) at the ITF could help to predict local recurrence in early stage oral squamous cell carcinoma cases.

Expression of Ki67 in Papillary Thyroid Microcarcinoma and its Clinical Significance

  • Zhou, Yuan;Jiang, Hong-Gang;Lu, Ning;Lu, Bo-Hao;Chen, Zhi-Heng
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권4호
    • /
    • pp.1605-1608
    • /
    • 2015
  • Purpose: To investigate the expression of Ki67 protein in papillary thyroid microcarcinoma(PTMC), and to analyze its clinical significance. Materials and Methods: Ki67 protein expression was evaluated in the tissues of 108 human PTMC and 50 other benign papillary hyperplasia of thyroid specimens using immunohistochemistry. Results: The expression intensity of Ki67 in PTMC and benign papillary hyperplasia of thyroid specimens were $1.45{\pm}1.83%$ and $0.46{\pm}0.46%$.The positive expression rates were 46.3% and 14%. There were significant differences between these two groups (p<0.01). There was no significant variation of the expression intensity and positive expression rates of Ki67 in PTMC with gender, age, position of the tumor and the level of TSH pre-operation (p>0.05), but these parameters varied with tumor size, invasion by membrane and cervical lymph node metastasis (p<0.05 or p<0.01). Conclusions: The expression of Ki67 in PTMC was related to tumor size, invasion by membrane and cervical lymph node metastasis, and could be the important indicator for judging clinical progress and estimating prognosis.

Ki-67 Immunostaining and its Correlation with Microvessel Density in Patients with Mutiple Myeloma

  • Himani, Bhankar;Meera, Sikka;Abhimanyu, Sharma;Usha, Rusia
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권5호
    • /
    • pp.2559-2564
    • /
    • 2016
  • Purpose: To compare Ki-67 index and microvessel density MVD) in multiple myeloma and non-myeloma patients and their correlation with each other and other prognostic markers. Materials and Methods: Forty patients were enrolled in this study between 2011-2013, 30 with multiple myelomas and 10 with non-malignant disease as controls. Proliferative activity was analyzed by Ki-67 and microvessel density (MVC) was assessed by CD34 and compared between two groups. In myeloma patients, correlation between Ki-67, MVD and other prognostic factors was assessed by Pearson correlation coefficient. Results: According to Durie Salmon staging criteria, 13 patients were of stage 1, 5 of stage II and 12 of stage III. Ki-67 expression showed a positive correlation with MVD (r=0.729, p<0.001) and was significantly higher (p<0.0001) in myeloma patients (range 35-80%, mean 60.1 %) as compared to controls (range 8-25%, mean 18.1%). $MVD/mm^2$ was also significantly (p<0.0001) higher in myeloma patients (range $62-237/mm^2$, mean $178.0/mm^2$) than controls (range $5.2-50/mm^2$, mean $18.3/mm^2$). Ki-67 and MVD, both increased progressively with increasing stage of myeloma. Ki-67 showed significant positive correlation with blood urea and lactate dehydrogenase and a significant negative correlation with serum albumin. MVD showed a significant positive correlation with blood urea, lactate dehydrogenase, serum creatinine, ${\beta}2$ microglobulin and skeletal lesions. Conclusions: Ki-67 and MVD are indicators of aggressiveness and poor prognosis having significant correlation with each other and other prognostic markers of multiple myeloma. Routine assessment of these markers may help to identify high risk patients, who may benefit from with more aggressive therapy.